Loading the section…
The price of Axogen, Inc. (AXGN) on October 9, 2026 is 36.13 USD, -0.14% on the day. Over 52 weeks the stock traded between 15.27 USD and 52.91 USD; the price now sits 55% of the way up that range. Over the past year the price changed by +110.55%. Market capitalization is 1.92 billion USD, rank 5 among 21 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 4 November 2026 · Earnings calendar
Change over the period shown (line colour): +131.75 %
Axogen, Inc. trades on Nasdaq under the ticker AXGN. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks AXGN has traded between 15.27 $ and 52.91 $. As of 9 October 2026 the price stood 55.42 % of the way from the 52-week low to the high.
Over one year AXGN shares rose 110.55 %; over six months they rose 13.05 %. Volatility over 90 days is 50.20 %. Dividends are not included: this is price change only, as of 9 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 8.1, above the sector median of 4.0. Price to book is 7.8, above the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 36.35 | 36.80 | 35.60 | 36.13 | 929,800 |
| 8 October 2026 | 35.98 | 36.32 | 35.44 | 36.18 | 1M |
| 7 October 2026 | 36.31 | 36.88 | 35.83 | 36.04 | 2M |
| 6 October 2026 | 37.23 | 37.61 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Axogen, Inc. (AXGN) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2026-03-31, revenue was 238.1m $, net income was -31.5m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:13631 PROGRESS BLVD. SUITE 400, ALACHUA, FL, 32615, US
Axogen, Inc. reported revenue of 238M $ and a net loss of 31M $ over the last four quarters. Net margin is −13.21 %. Revenue changed by +22.41 % year over year. Earnings per share are −0.64 $. Market capitalisation is 1.9B $.
AXGN has a return on equity of −12.85 %, above the sector median of −41.68 %. Return on assets is −10.87 %, above the sector median of −32.11 %. Operating margin is −3.79 %, above the sector median of −26.84 %.
| 49M |
| NXLNexalin Technology, Inc. | 3.63 | −11.68 % | 16M |
| CNMDCONMED Corporation | 44.42 | −1.53 % | 16M |
| CBLLCeriBell, Inc. | 23.63 | +2.07 % | 8M |
| INMDInMode Ltd. | 14.21 | +0.92 % | 7M |
| 35.82 |
| 36.31 |
| 2M |
| 5 October 2026 | 37.47 | 38.27 | 36.79 | 37.22 | 2M |
| 2 October 2026 | 39.92 | 39.92 | 36.97 | 37.39 | 3M |
| 1 October 2026 | 41.56 | 42.20 | 39.68 | 39.92 | 2M |
| 30 September 2026 | 42.35 | 43.09 | 41.75 | 41.92 | 1M |
| 29 September 2026 | 43.67 | 43.79 | 41.76 | 42.44 | 1M |
| 28 September 2026 | 43.23 | 43.94 | 42.46 | 43.36 | 885,500 |
| 25 September 2026 | 43.61 | 44.68 | 43.05 | 43.39 | 1M |
| 24 September 2026 | 43.18 | 43.95 | 42.55 | 43.32 | 796,600 |
| 23 September 2026 | 44.54 | 44.84 | 43.25 | 43.32 | 1M |
| 22 September 2026 | 46.17 | 47.00 | 44.00 | 44.54 | 1M |
| 21 September 2026 | 44.82 | 46.58 | 44.32 | 45.93 | 1M |
| 18 September 2026 | 44.94 | 45.66 | 44.16 | 44.23 | 1M |
| 17 September 2026 | 45.91 | 46.89 | 45.07 | 45.29 | 831,400 |
| 16 September 2026 | 44.87 | 46.35 | 44.03 | 45.44 | 1M |
| 15 September 2026 | 43.85 | 45.46 | 43.51 | 44.97 | 1M |
| 14 September 2026 | 41.55 | 44.00 | 41.55 | 43.78 | 2M |